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Rupture of a vulnerable atherosclerotic plaque causes thrombus
formation and precipitates cardiovascular diseases. In addition to
the thrombogenic content of a plaque, also the hemodynamic mi-
croenvironment plays a major role in thrombus formation. How
the altered hemodynamics around a plaque promote pathological
thrombus formation is not well understood. In this study, we
provide evidence that plaque geometries result in fluid mechanical
conditions that promote platelet aggregation and thrombus forma-
tion by increased accumulation and activity of vonWillebrand factor
(vWF) at poststenotic sites. Resonant-scanning multiphoton micros-
copy revealed that in vivo arterial stenosis of a damaged carotid
artery markedly increased platelet aggregate formation in the ste-
notic outlet region. Complementary in vitro studies using microflui-
dic stenotic chambers, designed to mimic the flow conditions in
a stenotic artery, showed enhanced platelet aggregation in the ste-
notic outlet region at 60–80% channel occlusion over a range of
input wall shear rates. The poststenotic thrombus formation was
critically dependent on bloodborne vWF and autocrine platelet
stimulation. In stenotic chambers containing endothelial cells, flow
provoked increased endothelial vWF secretion in the stenotic outlet
region, contributing to exacerbated platelet aggregation. Taken to-
gether, this study identifies a role for the shear-sensitive protein
vWF in transducing hemodynamic forces that are present around
a stenosis to a prothrombogenic microenvironment resulting in spa-
tially confined and exacerbated platelet aggregation in the stenosis
outlet region. The developed stenotic microfluidic chamber offers
a realistic platform for in vitro evaluation of shear-dependent throm-
bus formation in the setting of atherosclerosis.
Atherosclerosis is characterized by progressive growth of ath-erosclerotic plaques in the arterial circulation. In an advanced
stage of atherosclerosis, plaques will become stenotic and cause
progressive obstruction of the arterial lumen. A current theorem is
that rupture or erosion of a stenotic plaque is required for arterial
thrombus formation and ensuing thrombotic complications, such
as pulmonary embolism, myocardial infarction, or stroke (1). Bet-
ter understanding of the precise regulation of thrombus formation
in atherosclerotic vessel segments is critical for the improvement of
current antithrombotic treatments.
Biochemical and hemodynamic factors contribute to thrombus
formation at a vulnerable vessel wall (2–4). Thrombogenic com-
ponents exposed upon plaque rupture—e.g. tissue factor, colla-
gen and von Willebrand factor (vWF)—trigger initial activation
of platelets and the coagulation system (5–7). Stable recruitment
of platelets under flow to a growing thrombus involves vWF and
fibrinogen as main ligands, which interact with glycoprotein (GP)
Ib-V-IX and integrin αIIbβ3, respectively, as well as autocrine
agonists produced by platelets themselves (8, 9). There is growing
appreciation of the interplay of hemodynamics with this multi-
receptor process in plaque-containing areas (10). Intraluminal
growth of a developing plaque, even in the absence of thrombus
formation, will gradually alter the local blood flow dynamics (11).
The flow disturbances at sites of severe stenosis may even lead to
fatal occlusive thrombus formation in humans (12). Simulations
indicate that plaque geometries induce gradients in pressure, flow
velocity, and shear stress of the local blood flow, as a consequence
of which autocrine agonists may get trapped that enhance plate-
let activation (13). However, the mechanisms dictating shear-
dependent platelet aggregation at sites of atherosclerotic stenosis
remain poorly understood.
In the present study, we used fast resonant-scanning multi-
photon microscopy to investigate stenosis-dependent platelet
aggregation in the murine carotid artery in vivo. In addition, we
developed a microfluidic platform with stenotic flow channels to
investigate platelet aggregation at defined positions relative to
plaque-like geometries. Our data show that, both in vivo and in
vitro, the shear stress conditions downstream of a stenotic site
aggravate local platelet aggregation in a strongly vWF-dependent
manner. This work highlights a central role for the shear-sensitive
protein vWF in converting the fluid forces in the microenviron-
ment downstream of a stenotic geometry into prothrombotic re-
sponses in a partly occluded artery.
Results
Exacerbation of Platelet Aggregation Poststenosis in Mouse Carotid
Arteries in Vivo. The acute consequences of a vascular stenosis on
platelet aggregation dynamics were investigated in vivo in the
common carotid artery of C57BL/6 mice using fluorescence mi-
croscopy. Minor activation of the endothelium was applied
through topical application of 12.5% (wt/vol) ferric chloride for
a short period of 30 s to mimic the situation of moderate endo-
thelial dysfunction as in the setting of atherosclerosis. This led to
the formation of only small aggregates of fluorescently labeled
platelets, which were scattered over the area affected by ferric
chloride (Fig. 1A; 0–67 s). Subsequent induction of a stenosis by
localized vessel compression with a 27-gauge needle to reach 80%
lumen occlusion, markedly, resulted in an instantaneous growth
response of aggregates in the stenosis outlet region, whereas the
small aggregates in the stenosis inlet region remained unaffected
(Fig. 1B, Inset). Overall, the stenotic vessel compression induced
a greater than fourfold increase in thrombus size specifically in
the stenosis outlet region (Fig. 1B).
Resonant-scanning multiphoton microscopy was used to de-
termine the luminal thrombus composition inside the moving
carotid artery at submicrometer resolution (Methods). Mice were
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preinjected with platelets labeled with carboxyfluorescein diac-
etate succinimidyl ester (CFSE) in combination with Alexa Fluor-
labeled markers of platelet activation (labeled anti–P-selectin
mAb or fibrinogen), and intraluminal thrombus formation was
monitored in real time (Fig. 1C). The increased thrombus
mass observed in the stenosis outlet section showed high staining
for P-selectin that was associated with platelets close to the
vessel wall. Furthermore, the thrombus in the stenosis outlet was
enriched in fibrin(ogen) associated with the platelets. Jointly,
these results demonstrate that stenosis of an injured artery ex-
acerbates the thrombotic response immediately downstream of
the stenosis.
Enhanced Platelet Aggregation Poststenosis in Microchannels in
Vitro. To investigate how plaque geometries influence thrombus
formation, an in vitro microfluidic platform was developed with
multiple flow channels containing stenotic features of varying
dimensions. Design was such that key rheological parameters
were similar to those in the larger carotid arteries in humans (i.e.,
slopes of the stenosis, wall shear rates at the inlet and stenotic
regions, and maximal flow elongation rate), while making ad-
vantage of the small fluid volumes needed for the microchannels
(Table S1). We developed polydimethylsiloxane (PDMS) micro-
channels of 300 μm width, in which half-circular eccentric ste-
noses with a diameter of 600 or 1000 μm were present, i.e., two to
three times the channel width (Fig. 2A). Lumen reductions varied
from 20% to 80%, thus producing various degrees and slopes of
stenosis. The microchannels were mounted on a pattern-coated
coverslip, containing discrete patches (80 μm width) of immobi-
lized vWF/fibrinogen, i.e., principal platelet-adhesive components
in thrombus formation (Fig. 2A and Fig. S1A). Computational
analysis indicated that the wall shear rate was symmetrically dis-
tributed over the stenosis artifact. At 80% stenosis, it was eight-
fold higher in the apex region than in the prestenotic segment
(Fig. 2B and Fig. S1B). At an input wall shear rate of 1,000 s−1,
a platelet traveling through the stenosis thus experiences an in-
crease in shear rate to 8,000 s−1, followed by an identical decrease
after the stenosis (Fig. S1C). These calculations are in agreement
with experimental measurement of the velocity of flowing plate-
lets at 2 μm from the channel bottom (Fig. S1D).
To investigate the effect of stenotic geometries on platelet
activation, whole blood labeled with 3,30-dihexyloxacarbocyanine
iodide (DiOC6) was perfused through the channels containing
patches of vWF/fibrinogen. Upon perfusion at (arterial) input
wall shear rate of 1,000 s−1, aggregates formed of adhered pla-
telets, predominantly in the stenosis outlet region, as indicated by
a >2.5-fold increase in platelet deposition (Fig. 3A). In contrast,
only single platelets adhered in the stenosis inlet region and
in straight sections of the channel. Platelet aggregation in the
stenosis outlet region was typically dependent on the degree of
stenosis, being most prominent at 60–80% lumen reduction (Fig.
3B and Movie S1). Thrombus height ranged from single platelets
Fig. 1. Induced poststenotic thrombus formation in the murine carotid ar-
tery in vivo. Dissected mouse carotid arteries were subjected to brief (30 s)
topical application of 12.5% (wt/vol) FeCl3, and vessel stenosis was induced
by a 27-gauge needle. In control experiments, no stenosis was induced.
Intraluminal accumulation of fluorescence was monitored from preinjected
CFSE-labeled mouse platelets using intravital fluorescence microscopy. (A)
Wide-field fluorescence images showing thrombus formation downstream
of stenosis site. The dotted lines (from bright-field images) indicate positions
of vessel and needle; blood flow was from left to right. (Scale bar, 250 μm.)
(B) Total aggregate size of fixed areas at regions of the stenosis inlet and
outlet. Inset gives time plot of representative experiment. (C) Resonant
scanning multiphoton fluorescence images during thrombus formation of
preinjected labeled platelets (green), anti-P-selectin mAb (red), or fibrin
(ogen) (red) in the stenotic inlet and outlet regions. In cross-sections, the
carotid artery appears as an ellipse due to the angle between vessel and
image focus plane (23°). Data are means ± SD; n = 4 (*P < 0.05).
Fig. 2. Wall shear rate patterns in microfluidic PDMS channels with a ste-
notic shape. (A) Drawing of microchannel with width of 300 μm, eccentric
circular stenotic indentation (600- or 1,000-μm Ø), and lumen restriction of
20–80%. The channel bottom contains discontinuous strips (80 μm) with
immobilized vWF/fibrinogen. (B) Computational fluid dynamics analysis
displaying the wall shear rate (WSR) near the channel bottom in a micro-
channel with 20–80% stenosis (600-μm Ø) at 1,000 s−1 inlet WSR (0.5 mL/h).






































in the upstream and downstream regions to full channel height
(52 μm) in the outlet region. The enhanced platelet aggregation
in the stenosis outlet zone was present at inlet wall shear rates of
600, 1,000, and 2,000 s-1 (Fig. 3C), and was eliminated by pre-
treatment of the blood with blockers of GPIbα (6B4 mAb) or
integrin αIIbβ3 (c7E3 mAb). Similarly, treatment of the blood with
the platelet inhibitor, iloprost, prevented enhanced platelet ag-
gregation in the stenosis outlet region (Fig. 3C). Suppressing the
effects of autocrine mediators with ADP receptor blockers and
indomethacin had a strong inhibitory effect on platelet aggrega-
tion in the stenosis outlet region (Fig. 3C and Fig. S2).
In control studies with straight channels, we found that blood
perfusion up to a wall shear rate of 8,000 s−1 did not initiate platelet
aggregation (Fig. S3A). However, anticoagulation of the blood with
hirudin or D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone
(PPACK), instead of citrate, also yielded platelet aggregation
specifically in the stenotic outlet region (Fig. S3B). Detailed anal-
ysis of the platelet trajectories during flow indicated that this
poststenotic platelet aggregation was not due to translocation of
platelets from upstream to downstream patches, neither to lodging
of upstream-formed platelet aggregates (Fig. S4 and Movie S1).
Key Role of Bloodborne vWF in Stenosis-Dependent Platelet Aggregation.
Platelet adhesion under high shear conditions is critically depen-
dent on vWF binding to GPIbα. To assess whether plasma vWF
was a limiting factor in stenosis-dependent platelet aggregation,
normal whole blood was supplemented with 20 μg/mL (2.0 IU/mL)
purified vWF. This threefold increase in vWF concentration
resulted in a corresponding increase in the magnitude of platelet
aggregation in the stenosis outlet region (Fig. 4A, Left). No ag-
gregation was observed in the straight sections of the flow channel.
To confirm the importance of vWF, whole-blood samples were
used from patients with dilutional coagulopathy treated with 1-
desamino-8-D-arginine vasopressin (DDAVP) to increase plasma
levels of vWF and factor VIII. The administration of DDAVP
resulted in an overall 1.9-fold increase in aggregation response in the
stenosis outlet region (Fig. 4A, Center). Again, upstream and
downstream sections were not reactive. Furthermore, a reconstituted
system was used with washed platelets and red blood cells. In this
case, platelets did not aggregate in the absence of vWF but showed
asymmetric aggregation in the stenosis outlet region after supple-
mentation of 10 μg/mL vWF (Fig. 4A, Right). Confocal fluorescence
microscopy after 4 min of platelet-depleted whole-blood perfusion
revealed a significant increase in vWF staining in the stenotic region
compared with upstream sections of the channel (Fig. 4B). In-
terestingly, applying the wall shear rates present in the stenosis outlet
(∼5,700 s−1) and apex region (∼8,000 s−1) in straight channels did not
increase vWF staining intensity.
At high shear conditions, binding of the vWF A1-domain to
the GPIbα receptor induces a rise in cytosolic Ca2+, and sub-
sequent platelet activation (14). This was investigated with pla-
telets, loaded with the Ca2+ probe, Fluo-4, and reconstituted in
a medium with plasma and red blood cells [40% (vol/vol) hemat-
ocrit]. A larger fraction of surface-adherent platelets exhibited
transient elevation in Ca2+ in the inlet and outlet zones of the
stenosis, i.e., where the platelets were subjected to flow gradients
(Fig. 4C). Blocking of GPIbα with 6B4 mAb eliminated the Ca2+
rises at both sites, thus confirming the role of this receptor in
shear gradient-dependent platelet activation.
Enhanced Platelet Aggregation Poststenosis by Increased Endothelial
Secretion of vWF. Platelet aggregation in vivo relies on both he-
matological parameters and vascular factors. To investigate this,
microfluidic stenotic channels were used with endothelial cells,
cultured to a confluent monolayer (Fig. 5A). These endothelial
cells were subjected to buffer perfusion at a fluid wall shear rate
of 1,000 s−1. Markedly, cells that were located in the outlet region
of the stenosis displayed a strong increase in surface-expressed
vWF, such in contrast to cells at the stenosis inlet region. The
vWF staining pattern indicated strings of vWF multimers in the
outlet region (Fig. 5A, arrows). This is consistent with the finding
from others, reporting that cultured endothelial cells can release
Fig. 3. Exacerbated platelet aggregation in microfluidic channels at ste-
nosis outlet region. Platelets in whole blood were labeled with DiOC6 and
perfused through a stenotic microchannel (600- or 1,000-μm Ø and 20–80%
stenosis) at input wall shear rate of 1,000 s−1. (A) Platelet density at in-
dividual patches of vWF/fibrinogen around the stenosis apex normalized to
values obtained on the first patch. Note that platelet aggregate formation is
asymmetrically distributed toward the stenosis outlet region. (Scale bar, 100
μm.) (B) (Left) Mean platelet density in the stenosis outlet region at various
degrees of stenosis (normalized to values of the first patch at the channel
inlet). The sudden intensity reduction at 80% stenosis is due to an emboli-
zation event. (Right) Representative confocal fluorescence images of plate-
let aggregate formation at 20–80% stenosis at 120 s of blood flow. Note the
single adhered platelets at patches of vWF/fibrinogen before and after the
stenosis, and platelet aggregates in patches at the stenotic outlet region
(60–80% stenosis). (Scale bar, 100 μm.) (C) Mean platelet density in the
stenosis outlet region at various input wall shear rates and in the presence of
inhibitors, 6B4 (anti-GPIbα mAb), c7E3 (anti-αIIbβ3 mAb), ARA (autocrine re-
ceptor antagonists: cangrelor at 30 μM, MRS2179 at 100 μM, indomethacin
at 10 μM) or iloprost (prostacyclin analog, 55 nM). Data represent means ±
SD; n = 3–4 (*P < 0.05).













































multimeric vWF following histamine stimulation (15). Quantita-
tive analysis after vWF staining showed that the shear-induced
vWF multimers occupied a 15-fold higher surface area in the
outlet region, compared with the inlet region (Fig. 5B). However,
endothelial cells in channels not containing a stenosis failed to
produce strings of vWF within the same time frame, up to shear
rates of 8,000 s−1 (Fig. S3C).
Whole-blood perfusion through the endothelial-covered chan-
nels led to substantial platelet aggregation specifically in the
stenotic outlet region (Fig. 5C). Platelet aggregates grew to large
sizes (mean area, 13,474 μm2), whereas platelet aggregates in the
inlet region and further upstream regions remained only small
(mean, 1,378 μm2). In control experiments, the endothelial cells
were stimulated with histamine, to provoke vWF release before
blood perfusion. In this case, large-size platelet aggregates (mean
size, 6,496 μm2) were formed throughout the channel, hence also
in the straight upstream sections (Fig. 5D). These results reveal
compound effects of the hemodynamic shear stress in stenosis
outlet regions, which stimulate endothelial vWF secretion, and
vWF-dependent platelet aggregation, both facilitating pathologi-
cal thrombus formation.
Discussion
In this study we demonstrate both in vivo and in vitro—using
engineered stenotic microfluidic channels—that thrombus for-
mation is exacerbated at sites downstream of stenotic athero-
sclerotic plaque geometries. Increased platelet aggregation in the
stenotic outlet region strongly relies on plasma and endothelial
vWF, which causes spatially confined platelet activation (Fig. 6).
These findings shed light on the process of atherothrombosis in that
the stenotic geometry of a plaque, and the consequently altered
blood flow pattern, appears to be an important regulatory factor of
platelet aggregation and thrombus formation. Thus, plaque rup-
ture sites in vessel segments immediately downstream of a stenosis
may be at increased risk of triggering thrombus formation.
The phenomenon that shear rate gradients can influence
thrombus formation has recently been described (16). Microshear
gradients surrounding a thrombus recruit platelets in a down-
stream direction. Such clot asymmetry is also observed in the laser
injury model of thrombosis in mice (17). The present data sig-
nificantly extend this work in demonstrating the importance of
vWF acting as a regulator of platelet aggregation at poststenotic
sites with decreasing wall shear rate. Platelet aggregation at
poststenotic sites appears to be strictly dependent on the release
of platelet agonists and, hence, is fundamentally different from
the mechanism of microshear gradient-dependent platelet ag-
gregation, earlier described by Nesbitt et al. (16). Already in the
1970s, it was suggested that alterations in blood flow dynamics
around atherosclerotic plaques link to occlusive thrombus for-
mation (12), and that mild vascular damage in the presence
of lumen reduction has thrombotic consequences, such as in
the classical Foltz model of thromboembolism (18). Fluid dy-
namic studies from the 1990s reported that stenotic regions
influenced platelet aggregation by way of flow perturbations and
recirculation zones (19, 20). In particular, collagen ligands in
combination with extremely high shear rates were used to detect
poststenotic aggregate formation (21, 22). However, in the pres-
ent study, the flow conditions in the microfluidics channel were
Fig. 4. Role of vWF in stenosis-induced platelet aggregation. (A) Platelet den-
sity in stenotic (600-μm Ø) outlet regions at input wall shear rate of 1,000 s−1.
Values are normalized against control condition (open bars). (Left) Control whole
blood supplemented with 20 μg/mL vWF. (Center) Whole blood from patients
with dilutional coagulopathy was monitored pretreatment and posttreatment
with DDAVP. (Right) Effect of vWF addition (10 μg/mL) to 3 × 108/mL washed
platelets, reconstituted with 40% (vol/vol) red blood cells. (B) Representative
micrographs showing platelet-bound vWF (yellow) and platelets (grayscale) un-
der conditions of elongational flow in the stenosis channels and nonelongational
flow in straight channels. Platelet-depleted blood was perfused through the
stenosis channels at 1,000 s−1 input wall shear or through the straight
channels at 5,700 and 8,000 s−1 to represent wall shear rates present in the
stenosis outlet and apex, respectively. (Lower) Fluorescence staining in-
tensities of platelet-bound vWF at various positions relative to the stenosis
normalized to values upstream. vWF staining intensity at the apex and
outlet of the stenosis channels is increased compared with the straight
channels. (C) Effect of GPIb blockage (20 μg/mL 6B4 mAb) on shear-induced
Ca2+ responses of single, surface-adherent platelets. Shown are fractions of
surface-adherent platelets displaying a Ca2+ response. Data are means ± SD;
n ≥ 3 (*P < 0.05, **P < 0.01).






































purposely kept laminar, while vWF and fibrinogen were chosen
as adhesive ligands that best represent the surface of growing
thrombi. Under these conditions, we found that the combination
of weakly platelet-activating vWF/fibrinogen plus shear alterations
at a stenosis outlet is sufficient for a strong proaggregatory effect.
A useful measure for the variable wall shear rate to which
platelets are exposed is the integral shear history, i.e., the product
of shear rate and exposure time (23). A reported threshold of the
integral shear history for platelet aggregation in response to
constant shear is 50 Pa·s (24). In our study, the integral shear
history is <0.054 Pa·s; hence the platelet-activating effect of the
stenosis must be caused by additional factors other than the short
exposure to high shear stress.
Rises in cytosolic Ca2+ are required for full platelet activation,
e.g., by causing release of autocrine mediators (25). We found that
plasma vWF adhesion to surface-adherent platelets in the inlet
and outlet regions of a stenosis triggers GPIbα-dependent Ca2+
signaling, potentially by more easy unfolding of the adhered vWF
under conditions of elongational flow compared with constant flow
(26). Indeed, the binding of vWF to platelets was increased only
under elongational flow conditions, not constant flow, and led to
a symmetric distribution of vWF binding throughout the high shear
region of the stenosis. We could calculate that the elongational
shear rate was maximal in the inlet of the stenotic channels, and
displayed similar values for a stenosis in a carotid artery in humans
and the in vivo mouse model (Fig. S5 A–C). Although the sym-
metrical distribution of enhanced vWF deposition is consistent
with the symmetrical distribution of Ca2+ signaling in surface-
adherent platelets, it is in apparent contradiction with the asym-
metric (i.e., downstream) platelet aggregation. Thrombus for-
mation was maximum immediately downstream of the stenosis
apex and did not extend beyond the stenotic feature, which is
consistent with mathematical simulations showing that local
concentration profiles of autocrine agonists rapidly decline due
to diffusion effects (27). Indeed, thrombus formation in the
outlet region was eliminated in the presence of cyclooxygenase
inhibition and ADP receptor blockade. The high shear stress in
the stenosis apex may trigger release of thromboxane A2 and
ADP, which are known to contribute to aggregate formation at
high shear stress (28, 29), whereas the immediate reduction in
shear stress load in the outlet region favors autocrine agonist-
dependent platelet aggregation. The stenotic geometry couples
high shear stress-induced release of autocrine agonists with
a region of low shear stress. This coupling mechanism is not
present in nonstenotic channels and, as expected, did not in-
duce overt aggregate formation even under pathological shear
rates (8,000 s−1). However, in a straight channel, the coupling
mechanism has essentially been demonstrated by Neeves et al.
(30) who artificially introduced high levels of ADP at a site of
platelet adhesion to fibrinogen under low shear rate (250 s−1) and
observed overt platelet aggregation. The previously described
process of activation-independent platelet aggregation (31) may
well play a role in the stenosis apex, which in combination with the
coupling to a low shear zone exacerbates platelet aggregation.
Endothelial cells may further contribute to stenosis-induced
platelet aggregation by enhanced vWF secretion and accumulation
in the stenotic outlet region (Fig. 6). This is consistent with
observations that endothelial cells undergo flow-induced activation
(32), leading to vWF secretion from Weibel–Palade bodies (33),
and that vWF is a critical mediator of thrombus formation under
conditions of near-vascular occlusion (34). The current data of
geometry-dependent platelet aggregation in the poststenosis region
are compatible with evidence that mural thrombi are preferentially
formed in the downstream direction, once a semiocclusive ath-
erosclerotic plaque ruptures or denudates. Also, arteriograms show
that plaque growth after episodes of thrombosis occurs preferen-
tially in the downstream direction (35, 36). Furthermore, endo-
thelial cells located in the downstream side of plaques have been
shown to be apoptotic (37), procoagulant (38), and adhesive to
nonactivated platelets (39). There is also evidence that the geom-
etry of the downstream side of plaques is linked to vulnerability to
rupture. Culprit lesions compared with nonculprit lesions were
Fig. 5. Poststenotic vWF secretion enhances platelet aggregation in mi-
crochannels covered with endothelial cells. Confluent HUVECs in stenotic
microchannels were perfusedwith buffer or whole blood at an input wall shear
rate of 1,000 s−1. (A) (Left) Staining for cytoskeletal actin with FITC-conjugated
phalloidin. (Right) Staining for surface-expressed vWF in the stenosis outlet re-
gion after 1 min buffer perfusion. (B) Quantification of vWF staining in stenosis
inlet and outlet regions. (C) Platelet aggregate size after whole-blood perfusion
(1,000 s−1) at indicated locations relative to the stenosis. (D) Confocal images of
platelet aggregates formed on endothelial cells after whole-blood perfusion.
Platelets were labeled with DiOC6 (displayed with false color). Prior endothelial
stimulation with histamine (500 μM), causing aggregate formation in all chan-
nel sections. (Scale bars, 100 μm.) Data are means ± SD; n = 3–4 (*P < 0.05).
Fig. 6. Atherosclerotic geometries exacerbate pathological thrombus for-
mation poststenosis in a vWF-dependent manner. Platelet aggregation at
sites immediately downstream of vascular stenosis is promoted by multiple
spatially confined variables (indicated arbitrarily by the red scale bar). The
stenotic geometry induces a symmetrically distributed shear stress magni-
tude, being highest at the stenosis apex. Autocrine agonists are released
from platelets that pass through the high shear stress region of the stenosis
apex. Subsequent autocrine platelet stimulation is maximum immediately
downstream of the apex and diminishes rapidly due to dilutional effects of
the autocrine agonists. Elongational flow in the stenosis inlet activates
plasma vWF and leads to symmetrically distributed vWF adhesion to ad-
herent platelets. The symmetric shear stress effects on the endothelium re-
sult in increased vWF secretion from endothelial cells in the stenosis outlet
region. Taken together, the outlet region of stenotic geometries exacerbate
thrombus formation through spatially confining (i) increased levels of vWF
content, (ii) autocrine platelet stimulation, and (iii) shear deceleration.













































found to have a higher outflow angle with a maximum of 36.6° (40),
which closely resembles the outflow angle of 39° in our study.
In conclusion, we identified a central role for the shear-sen-
sitive protein vWF in promoting platelet aggregation at post-
stenotic sites with a negative shear rate gradient. This argues for
the monitoring of atherosclerotic plaque geometries and com-
paring these with local endothelial vWF release and plasma
levels of vWF, in predicting the risk of atherothrombosis.
Methods
For further details, see SI Methods.
In Vivo Stenosis Model. All experiments were approved by the Maastricht
University animal experimental and care committees. Carotid arteries of
C57BL/6 mice were carefully dissected free from surrounding tissue. Mice
were then injected i.v. with CFSE-labeled platelets, obtained from a donor
mouse (8), and with Alexa Fluor (AF)-546–labeled fibrinogen or AF-568 anti-
CD62P mAb, as appropriate. Mild vessel damage was induced by topical
application of 12.5% (wt/vol) ferric chloride for 30 s. Local stenosis was
achieved by indentation of the carotid wall with a 27-gauge needle con-
trolled by a micromanipulator. Thrombus formation was monitored by res-
onant-scanning multiphoton microscopy (Leica SP5 system). This technique
combines the deep penetration of two-photon microscopy (0.8 mm at
800-nm excitation) with a fast scanning rate (effective 25 frames/s) using the
resonant-scanning module, thus allowing high-quality recording of confocal
images from an intraluminal thrombus of a moving carotid artery.
In Vitro Stenosis Models. Microfluidic chips were poured from PDMS, using
a mold with a series of parallel microchannels (300-μm width, 52-μm height)
each with a one-sided stenosis of 20%, 40%, 60%, or 80% lumen reduction.
A micropattern with strips of immobilized vWF/fibrinogen was generated by
coating a glass coverslip with a mixture of vWF (20 μg/mL) and fibrinogen (50
μg/mL) in Hepes buffer, pH 7.45 (134 mMNaCl, 20 mMHepes, 12 mMNaHCO3,
2.9 mM KCl, 1 mMMgCl2, 0.34 mM Na2HPO4, 5 mM glucose), using a separate
meandering microfluidic channel (80-μm width). The PMDS microchannel chip
was then placed on the coverslip. Whole human blood [anticoagulated with
3.8% (wt/vol) sodium citrate, hirudin, or PPACK] was perfused through the
microchannels at 1,000 s−1 input wall shear rate, unless otherwise stated.
Blood samples were preincubated with DiOC6 (2 μg/mL) and/or platelet
antagonists before perfusion. Fast recording of confocal images was done
with a LSM Live-7 line-scanning system (Zeiss) operating at 50 Hz.
Endothelial Cell-Covered Microchannels. Human umbilical vascular endothelial
cells (HUVECs) (20 × 106 cells/mL) were seeded into stenotic microchannels
precoated with fibronectin (2 mg/mL), and grown overnight to confluency
under 5% CO2 atmosphere at 37 °C. Channels containing endothelial cells were
perfusedwith human blood or EBM-2medium (37 °C), and stained for release of
vWF using mouse anti-vWF monoclonal antibody (1:100) and FITC-labeled goat
anti-mouse IgG (1:100), added to the perfusion medium (no fixation). Surface
expression of vWF was visualized in real time by fluorescence microscopy.
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